Cliona M. Rooney

46.9k citations

388 papers · 31.4k indexed · 13 hit papers · h-index 93

Oncology top 0.01%
- CAR-T cell therapy research 187
- Viral-associated cancers and disorders 119
Immunology top 0.05%
- Immune Cell Function and Interaction 135
- Immunotherapy and Immune Responses 63
- T-cell and B-cell Immunology 39
Genetics top 0.05%
- Virus-based gene therapy research 114
Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 68
Hematology top 0.2%
Epidemiology
- Cytomegalovirus and herpesvirus research 131

Co-authors: Helen E. Heslop Malcolm K. Brenner Gianpietro Dotti Barbara Savoldo Adrian P. Gee Catherine M. Bollard Ann M. Leen Robert A. Krance
Cited by: Oncology Immunology Genetics
Journals: Blood (94 papers)Biology of Blood and Marrow Transplantation (30 papers)Molecular Therapy (28 papers)
Partner nations: United States Germany France

In The Last Decade

Cliona M. Rooney

382 papers receiving 30.9k citations

Hit Papers

13 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2025 Nature Medicine
2017 Molecular Therapy
2014 Blood
2013 Journal of Clinical Oncology
2011 Blood
2011 Journal of Clinical Investigation
2011 New England Journal of Medicine
2009 Blood
2008 Nature Medicine
2005 Blood
1998 Blood
1996 Nature Medicine
1995 The Lancet

Peers

Countries citing papers authored by Cliona M. Rooney

Since Specialization

Citations

This map shows the geographic impact of Cliona M. Rooney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cliona M. Rooney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cliona M. Rooney more than expected).

Fields of papers citing papers by Cliona M. Rooney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cliona M. Rooney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cliona M. Rooney. The network helps show where Cliona M. Rooney may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cliona M. Rooney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cliona M. Rooney Line = papers co-authored together Cliona M. Rooney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma Blood Advances ·Sandhya Sharma,Rossa Fitria Halim,Tim Sauer,Lisa Rollins,Dirk P. Dittmer,Cliona M. Rooney	2024	2
2	OFF‐THE‐SHELF CD30.CAR‐MODIFIED EPSTEIN‐BARR VIRUS‐SPECIFIC T CELLS (CD30.CAR EBVSTS) PROVIDE A SAFE AND EFFECTIVE THERAPY FOR PATIENTS WITH HODGKIN LYMPHOMA (HL) Hematological Oncology ·Carlos A. Ramos,David H. Quach,Premal Lulla,Rayne H. Rouce,Sandhya Sharma,二三男武田,Nazila Nouraee,M Antoine,Jakob Dig Koch,Sachin G. Thakkar,Birju Mehta,G Vourc'h,Emily M. Hsieh,Huimin Zhang,Bambi Grilley,Natalia Lapteva,Malcolm K. Brenner,Helen E. Heslop,Cliona M. Rooney	2023	8
3	Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy Journal for ImmunoTherapy of Cancer ·Sandhya Sharma,Mae Woods,Rossa Fitria Halim,Tim Sauer,Kathan Parikh,Michael Schmueck‐Henneresse,Huimin Zhang,Birju Mehta,Malcolm K. Brenner,Helen E. Heslop,Cliona M. Rooney	2023	8
4	A Costimulatory CAR Improves TCR-based Cancer Immunotherapy Cancer Immunology Research ·Bilal Omer,Henry Murillier,Thomas Pfeiffer,隆美小前,Jéssica Carvalho Dantas,Sandhya Sharma,Nazila Nouraee,Zhou Zi,Rosalía Anaya P.,G Vourc'h,Kari Sandouka,勝之山崎,Emily Salines,Thomas Shum,Stephen Gottschalk,Caroline Arber,Cliona M. Rooney	2022	19
5	CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity Blood ·Tim Sauer,Kathan Parikh,Sandhya Sharma,Bilal Omer,クルニヤワンサェフラー,Qian Chen,Linus Angenendt,Christoph Schliemann,Michael Schmitt,Carsten Müller‐Tidow,Stephen Gottschalk,Cliona M. Rooney	2021	142
6	NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors Cancer Immunology Research ·Robin Parihar,Charlotte Helena Rivas,Jéssica Carvalho Dantas,Bilal Omer,Natalia Lapteva,Leonid S. Metelitsa,Stephen Gottschalk,Cliona M. Rooney	2019	219
7	Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells Cancer Discovery ·Thomas Shum,Bilal Omer,Haruko Tashiro,Robert L. Kruse,Dimitrios L. Wagner,Kathan Parikh,Zhongzhen Yi,Tim Sauer,Daofeng Liu,Robin Parihar,Paul Castillo,Hao Liu,Malcolm K. Brenner,Leonid S. Metelitsa,Stephen Gottschalk,Cliona M. Rooney	2017	220
8	Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells Clinical Cancer Research ·Miyuki Tanaka,Haruko Tashiro,Bilal Omer,马灵姬,Jun Ando,Minhtran Ngo,Birju Mehta,Gianpietro Dotti,Paul R. Kinchington,Ann M. Leen,Claudia Rössig,Cliona M. Rooney	2017	81
9	Clinical responses with T lymphocytes targeting malignancy-associated κ light chains Journal of Clinical Investigation ·Carlos A. Ramos,Barbara Savoldo,Vicky Torrano,Brandon Ballard,Huimin Zhang,Olga Dakhova,Enli Liu,George Carrum,Rammurti T. Kamble,Adrian P. Gee,Zhuyong Mei,Meng-Fen Wu,Hao Liu,Bambi Grilley,Cliona M. Rooney,Malcolm K. Brenner,Helen E. Heslop,Gianpietro Dotti	2016	234
10	Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation Blood ·Ann M. Leen,Catherine M. Bollard,Adam Mendizabal,Elizabeth J. Shpall,Paul Szabolcs,Joseph H. Antin,Neena Kapoor,Sung‐Yun Pai,Scott D. Rowley,Partow Kebriaei,Bimalangshu R. Dey,Bambi Grilley,Adrian P. Gee,Malcolm K. Brenner,Cliona M. Rooney,Helen E. Heslop	2013	392
11	Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma Clinical Cancer Research ·Serena Perna,Biagio De Angelis,Daria Pagliara,Frederick Stevens,Lan Zhang,Aruna Mahendravada,Helen E. Heslop,Malcolm K. Brenner,Cliona M. Rooney,Gianpietro Dotti,Barbara Savoldo	2012	63
12	Evaluation of Long-term Transgene Expression in piggyBac-Modified Human T Lymphocytes Journal of Immunotherapy ·Yozo Nakazawa,Natalia García Duro,Daniel L. Galvan,Leslie E. Huye,Lisa Rollins,Cliona M. Rooney,Matthew H. Wilson	2012	21
13	Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4 Clinical Cancer Research ·Carolina Colli Cruz,Ulrike Gerdemann,Ann M. Leen,LU Shu-xi,Stephanie Ku,Patrick Perrenoud,Terzah M. Horton,Andrea M. Sheehan,Amanda Copeland,Anas Younes,Cliona M. Rooney,Helen E. Heslop,Catherine M. Bollard	2011	56
14	Aggressive peripheral CD70‐positive t‐cell lymphoma associated with severe chronic active EBV infection Pediatric Blood & Cancer ·Donald R. Shaffer,Andrea M. Sheehan,Zhongzhen Yi,Cheryl Rodgers,Catherine M. Bollard,Malcolm K. Brenner,Cliona M. Rooney,Helen E. Heslop,Stephen Gottschalk	2011	5
15	Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma Journal of Immunotherapy ·Chrystal U. Louis,Karin Straathof,Catherine M. Bollard,D J Marsh,Claudia Gerken,Teresita Lopez,M. Helen Huls,Andrea M. Sheehan,Meng-Fen Wu,Суслова Мария Юрьевна,Adrian P. Gee,Malcolm K. Brenner,Cliona M. Rooney,Helen E. Heslop,Stephen Gottschalk	2010	160
16	Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression Molecular Therapy ·Nabil Ahmed,Vita S. Salsman,Eric Yvon,Chrystal U. Louis,László Perlaky,Winfried S. Wels,J.H. Kwantes,Eugenie E Kleinerman,Martin Pulé,Cliona M. Rooney,Helen E. Heslop,Stephen Gottschalk	2009	167
17	Regression of Experimental Medulloblastoma following Transfer of HER2-Specific T Cells Cancer Research ·Nabil Ahmed,HatemA Kalantan,Barbara Savoldo,László Perlaky,Gianpietro Dotti,Winfried S. Wels,Meenakshi B. Bhattacharjee,Richard J. Gilbertson,H. David Shine,Heidi L. Weiss,Cliona M. Rooney,Helen E. Heslop,Stephen Gottschalk	2007	138
18	Treatment of Epstein-Barr virus-associated malignancies with specific T cells Advances in cancer research ·Stephen Gottschalk,Helen E. Heslop,Cliona M. Rooney	2002	43
19	Production of Genetically Modified Epstein-Barr Virus-Specific Cytotoxic T Cells for Adoptive Transfer to Patients at High Risk of EBV-Associated Lymphoproliferative Disease Journal of Hematotherapy ·Кудерова Татьяна Юрьевна,Catherine Y. Ng,Helen E. Heslop,Martha Holladay,昌男吉川,FU Fen-lin,Susan K. Loftin,Carol O. Rogers,Malcolm K. Brenner,Cliona M. Rooney	1995	103
20	Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferationbreakdown → The Lancet ·Cliona M. Rooney,(unknown),Catherine Y. Ng,Susan K. Loftin,Colton A. Smith,Alexander Ismael,Robert A. Krance,Malcolm K. Brenner,(unknown),(unknown),(unknown)	1995	942

About Cliona M. Rooney

Cliona M. Rooney is a scholar working on Oncology, Immunology and Genetics, having authored 388 papers that have together received 31.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (187 papers), Immune Cell Function and Interaction (135 papers), Cytomegalovirus and herpesvirus research (131 papers), Viral-associated cancers and disorders (119 papers), Virus-based gene therapy research (114 papers), Lymphoma Diagnosis and Treatment (68 papers), Immunotherapy and Immune Responses (63 papers) and T-cell and B-cell Immunology (39 papers). The work is most often cited by research in Oncology (24.6k citations), Immunology (12.6k citations) and Genetics (8.8k citations). Cliona M. Rooney has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Helen E. Heslop, Malcolm K. Brenner, Gianpietro Dotti, Barbara Savoldo, Adrian P. Gee, Catherine M. Bollard, Ann M. Leen, Robert A. Krance, Stephen Gottschalk and Hao Liu. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Molecular Therapy, Cytotherapy and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact